Revlimid® as Consolidation Treatment Chronic Lymphocytic Leukemia

NCT01600053 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
11
Enrollment
OTHER
Sponsor class

Stopped interim analysis showed that the trial will not meet the interim endpoint.

Conditions

Interventions

Sponsor

Thomas Kipps

Collaborators